• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Machine-learning model helps detect diabetic patients at risk for kidney damage

February 6, 2018 By Sarah Faulkner

Medial EarlySignMedial EarlySign touted data today from a study of its algorithm designed to identify diabetic patients who have the highest risk of developing renal dysfunction.

The company’s machine-learning model looks at data from electronic health records to make predictions about patients’ health. In this study, the company reported that the algorithm identified 45% of patients who experienced significant kidney damage within one year – 25% more patients than commonly-used clinical tools would have detected, according to Medial EarlySign.

“Immense efforts are invested in developing treatment protocols to reduce the number of patients who will develop renal dysfunction due to diabetes,” chief medical officer Dr. Ran Goshen said in prepared remarks. “Medial EarlySign’s algorithm can aid decision-makers, drug developers, insurers and providers to better allocate their capped resources and secure preferential clinical outcome as well. This can help reduce the likelihood for diabetes-related end-stage renal disease (ESRD).”

“The significant size and rapid growth of digital health databases now allow the application of advanced mathematical tools that can identify patterns in diverse patient populations in order to identify high-risk patients,” Dr. Itamar Raz, director emeritus of Hadassah University Hospital’s diabetes unit, added.

“Rather than relying only on small patient samples based on known risk factors, machine learning tools can reveal the slightest correlations among these parameters and discover additional risk indicators that can lead to improved prediabetic patient risk stratification.”

Kidney problems commonly plague people with diabetes, according to Medial EarlySign – in the U.S. between 2011 and 2012, more than 36% of adults with diabetes had diabetic nephropathy or some form of renal dysfunction.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Diagnostics, Featured, Hospital Care, Technology Tagged With: medialearlysign

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS